Donaldson Company DCI Life Sciences Segment — Net Sales
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Donaldson Company in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
The official record: Donaldson Company’s 10-Q, filed June 2, 2026, on SEC EDGAR. View the filing →
Ask your AI about Donaldson Company's life sciences segment — net sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Donaldson Company's life sciences segment — net sales?
- Donaldson Company (DCI) reported life sciences segment — net sales of $83.5M in Q1 2026.
- How has Donaldson Company's life sciences segment — net sales changed year-over-year?
- Donaldson Company's life sciences segment — net sales increased by 12.5% year-over-year, from $74.2M to $83.5M.
- What is the long-term trend for Donaldson Company's life sciences segment — net sales?
- Over 4 years (2021 to 2025), Donaldson Company's life sciences segment — net sales has grown at a 3.8% compound annual growth rate (CAGR), from $254.5M to $295.6M.
- What does life sciences segment — net sales mean?
- Total revenue earned from selling Life Sciences products after accounting for returns and discounts.
- How do you interpret life sciences segment — net sales?
- Higher sales indicate strong market adoption and successful product positioning in the life sciences sector.
- How does life sciences segment — net sales compare across companies?
- Benchmark against other specialized filtration or medical device manufacturers to assess market share growth.